Kevin Lind | Chief Financial Officer |
Amit Munshi | President & Chief Executive Officer |
Preston Klassen | Head of Research & Development. |
Alethia Young | Cantor Fitzgerald |
Joel Beatty | Citi |
Jason Butler | JMP Securities |
Joseph Stringer | Needham |
Joseph Schwartz | SVB Leerink |
Patrick Trucchio | Berenberg Capital Markets |
Good day, ladies and gentlemen, and welcome to the Arena Pharmaceuticals' Second Quarter 2019 Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time. [Operator Instructions]